Gut microbiome in MPN patients on Mediterranean diet, USA
114 gut metagenome samples from adults and elderly individuals with myeloproliferative neoplasms in California, USA, collected during a 15-week dietary intervention trial comparing Mediterranean diet counseling to standard US dietary guidelines. machine-written summary
103 samples · 114 runs · US · Adult · 2023 · 0.77 Gbp / sample · cohort The NUTRIENT Trial (NUTRitional Intervention among
Checked this project's papers and archive records yourself? Mark it human-verified.
what each source gave
| ✓ Sequence archive | 824 sample values (collection date, country, health condition, health condition detail, latitude, location region, longitude, subject id) |
| ○ Abstract / description | read; no usable statement |
| ○ Full text | read; no usable statement or table · PMC10746218, PMC10913729 |
| ✓ Supplementary tables | 400 sample values (age, bmi, sex, timepoint) |
| – External resources | not covered by the external resources we ingest |
| – User contribution | nothing uploaded yet |
| – Human verified | not yet checked by a person · I checked this project — verify it |
intervention — arms not resolved
Controlled / prescribed diet or feeding regimen design randomized_controlled_trial · population other_disease · Mediterranean diet counseling vs USDA diet, 15 weeks
“Mediterranean or standard 2020 US Guidelines for Americans dietary counseling” — abstract:37877698 (study level; per-sample arms are in the intervention column below)
longitudinal — not resolved
Schedule stated by the source: “stool at weeks 1, 6, 9, and 15” (time origin: enrolment); stated follow-up 3 mo.
Genera, mean relative abundance over 95 profiled gut samples of this project (Sandpiper SingleM profiles, GTDB R232; low-depth and non-metagenome profiles left out).
| field | samples | coverage | R1 | R2 | R3 | R4 |
|---|---|---|---|---|---|---|
| age_category | 103 | 100% | ||||
| country | 103 | 100% | 103 | |||
| health_condition | 103 | 100% | 103 | |||
| subject_id | 103 | 100% | 103 | |||
| collection_date | 103 | 100% | 103 | |||
| detailed_location | 103 | 100% | ||||
| health_condition_detail | 103 | 100% | 103 | |||
| latitude | 103 | 100% | 103 | |||
| location_region | 103 | 100% | 103 | |||
| longitude | 103 | 100% | 103 | |||
| age_at_collection_days | 100 | 97% | 100 | |||
| bmi | 100 | 97% | 100 | |||
| sex | 100 | 97% | 100 | |||
| timepoint_label | 100 | 97% | 100 |
- Characterizing the microbiome of patients with myeloproliferative neoplasms during a Mediterranean diet intervention. 2023 PMID 37877698 PMC10746218 own_data
- The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Results from a Randomized Phase I Pilot Study for Feasibility and Adherence. 2024 PMID 38391189 PMC10913729 unsure
Archive description
Myeloproliferative neoplasms (MPN) are a class of hematological malignancies which result in the overproduction of myeloid lineage cells. These malignancies result in increased cytokine production and inflammation, which correlate with worsened symptom burden and prognosis. Other than bone marrow transplantation, there is no cure for myeloproliferative neoplasms. As such, treatments focus on reducing thrombotic risk, inflammation, and symptom burden. Because current pharmacological treatments carry significant side-effects, there is a need to explore low-risk therapies. One alternative is the Mediterranean diet, which is rich in anti-inflammatory foods, reduces inflammatory biomarkers, and beneficially alters the gut microbiome. Here, we performed a 15-week clinical trial of 28 individuals with MPN who were randomized to dietary counseling based on either a Mediterranean diet or standard U.S. Guidelines for Americans. Our primary objective was to determine if MPN patients were able to adopt a Mediterranean eating style when supported with dietician counseling. As exploratory endpoints, we investigated the impact of diet and inflammation on the gut microbiome. Using shotgun metagenomic sequencing, we found that microbiome diversity and composition were stable throughout the study duration in both cohorts. Furthermore, we discovered significant differences in the microbiomes between MPN subtypes, such as increased beta-dispersion in subjects with myelofibrosis. Lastly, we found several significant correlations between the abundances of multiple bacterial taxa and cytokine levels. Together, this study provides insight into the interaction between diet, inflammation, and the gut microbiome.
How this project entered the registry
Classified as human gut / stool shotgun DNA metagenome of adult by sonnet_x2 with confidence 0.75. Assay shotgun_dna.
- host run.host_tax_id · “9606”
- body site run.scientific_name · “gut metagenome”
- life stage study.description · “28 individuals with MPN who were randomized”
Evidence examples (one per field × route)
| sample | field | value | route | conf. | source | quote |
|---|---|---|---|---|---|---|
| SAMN32601121 | age_at_collection_days | 25933 | R2 | 0.85 | paper.supp.mbio.02308-23-s0002.csv[!Age] | 71 |
| SAMN32601121 | bmi | 30.0 | R2 | 0.85 | paper.supp.mbio.02308-23-s0002.csv[!BMI] | 30 |
| SAMN32601121 | collection_date | 2020-09-30 | R1 | 0.90 | biosample.attribute:collection_date | 2020-09-30 |
| SAMN32601121 | country | US | R1 | 0.90 | sample.attr.geo_loc_name | USA: California |
| SAMN32601121 | health_condition | other_cancer | R1 | 0.85 | biosample.attribute:env_broad_scale | human gut |
| SAMN32601121 | health_condition_detail | human gut | R1 | 0.85 | biosample.attribute:env_broad_scale | human gut |
| SAMN32601121 | latitude | 33.4700 | R1 | 0.90 | biosample.attribute:lat_lon | 33.47 N 117.53 W |
| SAMN32601121 | location_region | California | R1 | 0.85 | biosample.attribute:geo_loc_name | USA: California |
| SAMN32601121 | longitude | -117.5300 | R1 | 0.90 | biosample.attribute:lat_lon | 33.47 N 117.53 W |
| SAMN32601121 | sex | male | R2 | 0.85 | paper.supp.mbio.02308-23-s0002.csv[!Sex] | M |
| SAMN32601121 | subject_id | FEA02-1 | R1 | 0.85 | sample.attr.unique_id | FEA02-1 |
| SAMN32601121 | timepoint_label | 1 | R2 | 0.85 | paper.supp.mbio.02308-23-s0002.csv[!week] | 1 |
Sequencing
114 runs over 103 samples · mean 0.70 Gbp per run (median 0.77 Gbp, total 79.28 Gbp; 114 runs with a base count) · layout PAIRED 114 · platform ILLUMINA 114 · models Illumina HiSeq 4000 (114) · 86% of runs with a Sandpiper profile · first public 2023-10-20
Authors (22)
Avelar-Barragan J first · Mendez Luque LF · Nguyen J · Nguyen H · Odegaard AO · Fleischman AG · Whiteson KL last · Soyfer EM · Liu J · Chen JH · Mehrotra N · Huang X · Kosiorek HE · Dueck A · Himstead A · Heide E · Lem M · El Alaoui K · Mas E · Scherber RM · Mesa RA · Odegaard A
Downloads
PRJNA918651.csv.gz (3.7 KB) · parquet (75.6 KB) — all 103 samples, every field with route and confidence · PRJNA918651_determinations.csv.gz (8.1 KB) — 1,224 evidence rows